Chronological change in alpha‐fetoprotein levels in hepatocellular carcinoma after eradication of hepatitis C virus
- 28 May 2020
- journal article
- letter
- Published by Wiley in Liver International
- Vol. 40 (9), 2305-2306
- https://doi.org/10.1111/liv.14544
Abstract
No abstract availableFunding Information
- Japan Agency for Medical Research and Development (JP19fk0210022, JP20fk0210066, JP20fk0210058)
This publication has 5 references indexed in Scilit:
- Hepatocellular carcinoma surveillance, early detection and survival in a privately insured US cohortLiver International, 2020
- Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trialThe Lancet Infectious Diseases, 2017
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 InfectionThe New England Journal of Medicine, 2014
- Post-treatment Levels of α-Fetoprotein Predict Incidence of Hepatocellular Carcinoma After Interferon TherapyClinical Gastroenterology and Hepatology, 2013
- α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis CHepatology, 2013